CD95 _ FAS
- Known as:
- CD95 _ Fas Cell Surface Death Receptor
- Catalog number:
- 4Fs41-SA8
- Product Quantity:
- 1 mg
- Category:
- -
- Supplier:
- ACR
- Gene target:
- CD95 _ FAS
Related genes to: CD95 _ FAS
- Gene:
- FAS NIH gene
- Name:
- Fas cell surface death receptor
- Previous symbol:
- FAS1, APT1, TNFRSF6
- Synonyms:
- CD95, APO-1
- Chromosome:
- 10q23.31
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-25
- Date modifiied:
- 2019-04-23
Related products to: CD95 _ FAS
Related articles to: CD95 _ FAS
- The risk assessment for video display terminal (VDT) operators in occupational settings often relies on indirect estimates, such as self-reported screen time, which may not accurately reflect the true visual workload. The objective is to assess visual workload in VDT workers by measuring active screen fixation time with a non-invasive monitoring system and to explore its relationship with ocular surface alterations and fatigue-related indicators. - Source: PubMed
Publication date: 2026/06/24
Marelli EdoardoRuongo DavideBeschi GiacomoValsecchi NicolòRomano VitoSemeraro FrancescoDalola SimoneSala EmmaTomasi CesareFerrari VittorioFerrari MarcoDe Palma Giuseppe - LARC patients exhibit heterogeneity in their response to total neoadjuvant therapy (TNT). This study aims to screen and identify plasma biomarkers associated with treatment response to TNT in patients with locally advanced rectal cancer (LARC) to predict pathological complete response (pCR). - Source: PubMed
Publication date: 2026/06/08
Zhu ZonglinWen KaizhenZou BaoyiKang YanhuaChen JingqingZhu BinFan LipingHuang Haobo - Casirivimab and imdevimab (CAS+IMD) has been shown to improve clinical outcomes (death/mechanical ventilation) in seronegative hospitalized patients with COVID-19. The objective of the current analysis was to assess whether time to administration of CAS+IMD, from the start of COVID-19 symptoms, influenced these outcomes. - Source: PubMed
Publication date: 2026/06/18
Mylonakis EleftheriosSullivan AmySomersan-Karakaya SelinYou XiaojunLyu JiangnanShehadeh FadiGeba Gregory P - Obesity is a global metabolic challenge that leads to excessive fat accumulation and adipose tissue dysfunction due to the disruption of the balance between energy intake and consumption. This study focuses on whether Erchen Decoction promotes high-fat diet-induced white fat browning in obese rats through the SP1/SREBP/UCP1 signaling pathway, thereby improving obesity. - Source: PubMed
Publication date: 2026/06/23
Luo YueWang MengzhenLiu DonglinGuo FengyiSong NanJin ZheLiu ZiyuYang Xiao - This paper addresses the swing attenuation problem in quadrotor slung-load systems, which is challenging due to nonlinearity, underactuation, and strong dynamic coupling. A robust partitioned control strategy is proposed to handle model uncertainties, external disturbances, and load variations. By establishing the differential flatness of the system with load position and quadrotor yaw angle as flat outputs, the dynamics are partitioned into a fully actuated subsystem (FAS) and an underactuated subsystem (UAS). For the FAS, a novel adaptive nonsingular fast integral terminal sliding mode (AFITSM) controller is developed. It ensures finite-time convergence and enhances robustness through online estimation of lumped uncertainties. For the UAS, an overall sliding mode control (OSMC) strategy is formulated to coordinate lateral motion for swing damping. Comprehensive validation studies demonstrate that the proposed AFITSM-OSMC reduces tracking RMSE by 89%-99% and swing angle by 87%-93% compared to benchmark methods, while guaranteeing finite-time convergence within 1.7s under various uncertainties and disturbances. Under dynamic load variations, it limits maximum swing to 7.2 and achieves rapid stabilization, whereas benchmarks fail to settle. Moreover, control chattering is drastically suppressed, and peak torque rates are reduced by over 85%. The scheme offers superior tracking precision, rapid swing attenuation, robustness, and practical deployability. - Source: PubMed
Publication date: 2026/06/19
Sun HuiyuGu XinyanZheng KunWei Zhong